Answers are grounded in this paper and cite their sources.
Case report describes carotid stenosis in a patient receiving tyrosine kinase inhibitors, highlighting potential vascular risks associated with targeted leukemia therapy.
Tyrosine kinase inhibitors are considered as highly effective and relatively safe drugs for the treatment of chronic myeloid leukemia. If several side effects on short and long term are well known and described, their involvement in the development of carotid stenosis remains unclear. Here, we describe a case of carotid stenosis in a patient receiving tyrosine kinase inhibitors and discuss the current literature.
No takes yet. Share an insight, caveat, or question.
Hersant et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: